Epa and Abnormal posturing - a phase IV clinical study of FDA data
Summary:
We study 626 people who take Epa (epa (eicosapentaenoic acid)) or have Abnormal posturing. No report of Abnormal posturing is found in people who take Epa.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Epa?
Epa has active ingredients of epa (eicosapentaenoic acid). It is often used in high blood cholesterol. eHealthMe is studying from 623 Epa users. Check the latest studies of Epa.
What is Abnormal Posturing?
Abnormal posturing: no further information found. Check the latest studies of Abnormal posturing.
No report is found.
Do you take Epa and have Abnormal posturing?
- Check whether Abnormal posturing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Epa:
- Epa (623 reports)
Abnormal posturing treatments and more:
- Abnormal posturing (3 reports)
How severe was Abnormal posturing and when was it recovered:
Expand to all the drugs that have ingredients of epa (eicosapentaenoic acid):
Browse all side effects of Epa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Abnormal posturing:
Browse all the conditions that are associated with Abnormal posturing:
How the study uses the data?
The study uses data from the FDA. It is based on epa (eicosapentaenoic acid) (the active ingredients of Epa) and Epa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Metoclopramide and Diabetic Ketoacidosis for Women aged 20-29 - now
- Metoclopramide and Ketoacidosis for Women aged 20-29 - a second ago
- Metoclopramide and Dka for Women aged 20-29 - a second ago
- Metoclopramide and Diabetic Coma for Women aged 20-29 - a second ago
- Halcion and Famotidine drug interactions for men aged 60+ - 7 seconds ago
- Carvedilol and Speech Impairment (Adult) for Men aged 50-59 - 11 seconds ago
- Carvedilol and Slurred Speech for Men aged 50-59 - 11 seconds ago
- Carvedilol and Language Impairment for Men aged 50-59 - 12 seconds ago
- Carvedilol and Inability To Speak for Men aged 50-59 - 12 seconds ago
- Carvedilol and Dysphasia for Men aged 50-59 - 12 seconds ago